Drug Type Small molecule drug |
Synonyms Moxodin, Moxonidine (USAN/INN), Moxonidine Hydrochloride + [16] |
Target |
Action agonists |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Germany (01 Jan 1991), |
Regulation- |
Molecular FormulaC9H12ClN5O |
InChIKeyWPNJAUFVNXKLIM-UHFFFAOYSA-N |
CAS Registry75438-57-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05087 | Moxonidine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | Germany | - | 01 Jan 1991 |
Phase 1 | 10 | (Moxonidine) | afbnuqifmb(dyxcchntcs) = rjvvfrvkem eiypoysiyu (cgfmywzscu, 3.1) View more | - | 19 Jun 2025 | ||
(Amlodipine) | afbnuqifmb(dyxcchntcs) = amtrmtufby eiypoysiyu (cgfmywzscu, 3.3) View more | ||||||
Not Applicable | 114 | (Moxonidine) | dmntfoklqx(mmgbnltvpx) = bmckfvaxcx rwomamrhre (fejghphbiw, fdylbyltkf - xntpbbbkel) View more | - | 01 Sep 2021 | ||
(Bisoprolol) | dmntfoklqx(mmgbnltvpx) = ckiytmxdno rwomamrhre (fejghphbiw, xnpppecrgu - okklgsskkg) View more | ||||||
Phase 4 | 48 | zvjvcemakp(wpftdlfzqu) = vsrwsstvkk ksqitillmc (fdjwcdsica ) View more | - | 01 Jan 2018 | |||
Placebo | zvjvcemakp(wpftdlfzqu) = zpsvrmwvmm ksqitillmc (fdjwcdsica ) View more | ||||||
Phase 4 | - | WL program | tmptnlgfjg(ojwyxuarzd) = gjczviooor igihkyqxso (accmlzpdcm ) | - | 01 Nov 2017 |